<?xml version="1.0" encoding="UTF-8"?>
<ref id="med21743-bib-0549">
 <label>549</label>
 <mixed-citation publication-type="journal" id="med21743-cit-0549">
  <string-name>
   <surname>Yamazaki</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Shimosaka</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Sasaki</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Matsumura</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Tukiyama</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Tokiwa</surname>
   <given-names>T.</given-names>
  </string-name>
  <article-title>(+)‐Syringaresinol‐di‐O‐beta‐D‐glucoside, a phenolic compound from 
   <italic>Acanthopanax senticosus</italic> Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein‐1 and/or nuclear factor‐kappaB activities
  </article-title>. 
  <source xml:lang="en">Toxicol In Vitro</source>. 
  <year>2007</year>;
  <volume>21</volume>:
  <fpage>1530</fpage>‐
  <lpage>1537</lpage>.
  <pub-id pub-id-type="pmid">17561367</pub-id>
 </mixed-citation>
</ref>
